BrightGene Bio-Medical Technology Co

BrightGene Bio-Medical Technology Co PP&E per Employee

The PP&E per Employee of BrightGene Bio-Medical Technology Co (688166.SS) as of Nov 22, 2026 is 1.84 M CNY. In the previous year, PP&E per Employee was 1.22 M CNY — a change of 50.60% (higher).

PP&E per Employee

1.84 MCNY

YoY

50.60%

Last updated:

PP&E per Employee of BrightGene Bio-Medical Technology Co is 2022 1.84 M CNY. PP&E per Employee of BrightGene Bio-Medical Technology Co was 2021 1.22 M CNY. It decreases by 50.60% higher compared to the previous year.

The BrightGene Bio-Medical Technology Co PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2016
118,433.17 CNY
Jan 1, 2017
134,046.60 CNY
Jan 1, 2018
196,444.83 CNY
Jan 1, 2019
216,920.61 CNY
Jan 1, 2020
401,154.89 CNY
Jan 1, 2021
1.22 M CNY
Jan 1, 2022
1.84 M CNY
The BrightGene Bio-Medical Technology Co PP&E per Employee history
YEARPP&E per EmployeeYoY
1.84 MCNY+50.60%
1.22 MCNY+204.63%
401,154.89CNY+84.93%
216,920.61CNY+10.42%
196,444.83CNY+46.55%
134,046.60CNY+13.18%
118,433.17CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BrightGene Bio-Medical Technology Co Stock analysis

What does BrightGene Bio-Medical Technology Co do? BrightGene Bio-Medical Technology Co., Ltd. generates revenue by researching, developing, and manufacturing biopharmaceuticals, medicines, and special generic active pharmaceutical ingredients and finished dosage forms. The company's product portfolio centers on antifungal, antiviral, and immunosuppressive APIs, alongside other APIs and preparations. Its generic drug offerings specifically include entecavir, caspofungin, micafungin, posaconazole, everolimus, and fondaparinux sodium. The firm sells these products to customers in both domestic and overseas markets. By leveraging its capabilities in producing essential active pharmaceutical ingredients and finished dosage forms, the company serves the broader pharmaceutical sector through its established manufacturing and research operations. BrightGene Bio-Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BrightGene Bio-Medical Technology Co stock

PP&E per Employee of BrightGene Bio-Medical Technology Co is 1.84 M CNY in 2022.

PP&E per Employee of BrightGene Bio-Medical Technology Co changed from 1.22 M CNY to 1.84 M CNY, representing a 50.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee BrightGene Bio-Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's BrightGene Bio-Medical Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — BrightGene Bio-Medical Technology Co

All Key Metrics — BrightGene Bio-Medical Technology Co